Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia
Chris L. Pashos(Oldham Council), Zeba M. Khan(Bristol-Myers Squibb (Switzerland)), Mark A. Weiss(Thomas Jefferson University), Nicole Lamanna(Memorial Sloan Kettering Cancer Center), Jeff P. Sharman(Willamette Valley Cancer Institute and Research Center), David L. Grinblatt(NorthShore University HealthSystem), Susan Lerner(Molecular Templates (United States)), Charles M. Farber(Morristown Medical Center), Gale Harding(Policy Analysis (United States)), Thomas K. Street(Bristol-Myers Squibb (Switzerland)), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Arlene S. Swern, Kristen Sullivan(Tufts University), Ian W. Flinn(Tennessee Oncology), M. Kozloff(Ingalls Memorial Hospital), Neil E. Kay(Mayo Clinic)
Cited by 33
Related Papers
Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k